MEDP
$599.47+0.23%
as of close, Oct 2, 2026
☾ AH $599.47 +0.23%
MEDP — Medpace Holdings Inc. price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
VolumeEEEE
100.0200.0300.0400.0500.0600.005.0M10.0M$599.47—20162019202120242026
2026-10-02
Price$599.47
MA20$529.40
MA50$524.88
Vol1.6M
Key stats
Price data
- Price
- $599.47
- Change YTD
- +6.73%
- Next earnings
- Oct 21, 2026 · After close
- Market cap
- 16.7B
- Enterprise value
- 16.4B
- Shares outstanding
- 27.9M
- 52W low
- $373.00
- 52W high
- $677.90
- From 52W high
- -11.57%
- From 52W low
- +60.72%
- 52W range
- 74%
- Beta
- 1.14
Volume
- Rel volume
- 1.29×
- 30D volume
- 235.3K
- 30D $ vol
- 143.3M
Insider trading
- Insider net 1W
- −$31.8M
- Insider net 1M
- −$125.9M
- Insider net 3M
- −$208.5M
- Insider net 1Y
- −$230.3M
Form 4 transactions by trade date, as filed; latest on file 2026-09-30.
Fundamentals
- Sales (ttm)
- 2.8B
- Sales/share
- $99.68
- EPS (ttm)
- $17.05
- FCF (ttm)
- 706.7M
- FCF/share
- $25.32
- Book value/share
- $15.54
- Net margin
- 17.67%
- ROE
- 113.29%
- ROA
- 23.89%
- Current ratio
- 0.73
Growth (CAGR, ttm) · 10Y
- Sales
- +24.69%+18.48%+22.03%+21.54%
- Net income
- +17.51%+22.30%+22.87%+60.55%
- FCF
- +21.90%+23.69%+22.49%+23.15%
- Shares
- -0.65%-2.98%-4.87%-1.61%
Per-share growth (CAGR, ttm) · 10Y
- EPS
- +26.68%+26.75%+29.66%+66.28%
- Sales/share
- +25.50%+22.12%+28.27%+23.36%
- FCF/share
- +22.69%+27.49%+28.75%+25.00%
- Book value/share
- +153.53%+6.70%-8.16%+0.37%
- Price
- +11.81%+35.19%+25.09%+34.96%
- Total return
- +11.81%+35.19%+25.09%+34.96%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 35.2×
- P/OI (ttm)
- 28.7×
- Fwd P/E
- 31.9×
- P/S (ttm)
- 6.0×
- P/B (mrq)
- 38.6×
- P/FCF (ttm)
- 23.7×
- EV/EBITDA (fy)
- 26.8×
- EV/Sales (ttm)
- 5.9×
- FCF yield (ttm)
- 4.22%
- Buyback yield (realized, 1y)
- 0.65%
- Shareholder yield (realized, 1y)
- 0.65%
- Buyback yield (cash, ttm)
- 1.79%
- Shareholder yield (cash, ttm)
- 1.79%
Vs own 10Y history
- P/E
- 59th
- P/OI
- 71st
- P/S
- 82nd
- P/B
- 94th
- P/FCF
- 77th
Bar = where today’s multiple sits in MEDP’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return · as of 2026-10-02
1D
+0.23%
5D
-3.14%
1M
+1.09%
3M
+7.51%
YTD
+6.73%
1Y
+11.81%
5Y
+206.43%
Recent filings
- Sep 30Insider sale · Troendle August J. (President & CEO · Director · 10% owner) sold 21,966 shares for $13.7M at $625.47
- Sep 29Insider sale · Troendle August J. (President & CEO · Director · 10% owner) sold 26,701 shares for $16.6M at $621.02
- Sep 28Insider sale · Troendle August J. (President & CEO · Director · 10% owner) sold 2,410 shares for $1.5M at $620.07
- Sep 25Insider sale · Troendle August J. (President & CEO · Director · 10% owner) sold 154 shares for $96K at $620.60
- Sep 24Insider sale · Troendle August J. (President & CEO · Director · 10% owner) sold 27,833 shares for $17.3M at $621.33
Financial statements
Open full MEDP financials →Loading financial statements…
Related Health Care
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| NVS | Novartis AG | -13.21% | -0.04% |
| NVO | Novo Nordisk A/S | -20.21% | -0.21% |
| SNY | Sanofi ADS | -10.23% | -1.84% |
| GSK | GSK plc American Depositary Shares (Each representing two Ordinary Shares) | -6.76% | -0.32% |
| NTRA | Natera Inc. | +26.20% | +0.46% |
| ARGX | argenx SE American Depositary Shares | -12.90% | -1.79% |
| TAK | Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) | -3.09% | +0.00% |
| TEVA | Teva Pharmaceutical Industries Limited American Depositary Shares | +5.44% | +0.56% |
